Vapiprost Hydrochloride-impurities | Pharmaffiliates

vapiprost hydrochloride

vapiprost hydrochloride events and occlusive vascular disease. Phase III trials were underway in Japan for the treatment of deep vein thrombosis. Reference standards of Vapiprost Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Vapiprost Hydrochloride - API Standards 
    [catalogue_number] => PA 22 16000
    [category_ids] => ,80,78,70,82,71,
    [chemical_name] => 
    [weight] => 514.10
    [form] => C30H40ClNO4
    [cas] => 87248-13-3
    [pslug] => 87248-13-3-vapiprost-hydrochloride-api-pa2216000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 22 16000

Vapiprost Hydrochloride - API Standards


  • Catalogue No.:PA 22 16000

  • CAS :

    87248-13-3

  • Molecular Formula : C30H40ClNO4

  • Molecular Weight : 514.10